MD3222F1 - Metoda de diagnostic al cancerului endometrial - Google Patents

Metoda de diagnostic al cancerului endometrial

Info

Publication number
MD3222F1
MD3222F1 MDA20060093A MD20060093A MD3222F1 MD 3222 F1 MD3222 F1 MD 3222F1 MD A20060093 A MDA20060093 A MD A20060093A MD 20060093 A MD20060093 A MD 20060093A MD 3222 F1 MD3222 F1 MD 3222F1
Authority
MD
Moldova
Prior art keywords
endometrial cancer
diagnosis
endometrial
cancer diagnosis
concentration
Prior art date
Application number
MDA20060093A
Other languages
English (en)
Other versions
MD3222G2 (ro
Inventor
Dumitru Sofroni
Lilian GUTU
Katja Tenner
Anatolie CERNII
Mihail Todiras
Michael Bader
Original Assignee
Institutia Medico-Sanitara Publica Institutul Oncologic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutia Medico-Sanitara Publica Institutul Oncologic filed Critical Institutia Medico-Sanitara Publica Institutul Oncologic
Priority to MDA20060093A priority Critical patent/MD3222G2/ro
Publication of MD3222F1 publication Critical patent/MD3222F1/ro
Publication of MD3222G2 publication Critical patent/MD3222G2/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Inventia se refera la medicina, in special la oncologie si poate fi utilizata pentru diagnosticul neinvaziv precoce si pentru confirmarea diagnosticului de cancer endometrial. Esenta inventiei constain determinarea concentratiei de ARN mesager al triptofanhidroxilazei-1 in tesuturile endometrial si miometrial, si in cazul cand in tesutul endometrial concentratia este de 2…100 ori mai mare, se stabileste diagnosticul de cancer endometrial. Rezultatul inventiei consta in posibilitatea diagnosticarii precoce diferentiate a cancerului endometrialpentru stabilirea metodei eficiente de tratament pre- si postoperator.
MDA20060093A 2006-03-22 2006-03-22 Metodă de diagnostic al cancerului endometrial MD3222G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060093A MD3222G2 (ro) 2006-03-22 2006-03-22 Metodă de diagnostic al cancerului endometrial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060093A MD3222G2 (ro) 2006-03-22 2006-03-22 Metodă de diagnostic al cancerului endometrial

Publications (2)

Publication Number Publication Date
MD3222F1 true MD3222F1 (ro) 2007-01-31
MD3222G2 MD3222G2 (ro) 2007-08-31

Family

ID=37776647

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060093A MD3222G2 (ro) 2006-03-22 2006-03-22 Metodă de diagnostic al cancerului endometrial

Country Status (1)

Country Link
MD (1) MD3222G2 (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3499G2 (ro) * 2007-10-12 2008-09-30 Общественное Медико-Санитарное Учреждение Онкологический Институт Metodă de tratament diferenţiat al cancerului endometrial
MD492Z (ro) * 2011-08-17 2012-10-31 Лорена МЕДНИКОВ Metodă de determinare a răspândirii cancerului gastric de tip intestinal

Also Published As

Publication number Publication date
MD3222G2 (ro) 2007-08-31

Similar Documents

Publication Publication Date Title
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
MX347525B (es) Inhibidores de tirosina cinasa de bruton.
HUP0302332A2 (hu) Génkimutatási eljárás ErbB-antagonistával végzett rákterápiára adott hatékony reakció valószínûségének növelésére
HK1202561A1 (en) Antibody bound to anionic phospholipid and aminophospholipid, therapeutic and imaging uses thereof
MY185858A (en) Specific binding proteins and uses thereof
MX2011010390A (es) Conjugados, particulas, composiciones de agentes polimericos y metodos relacionados de uso.
EA200900203A1 (ru) Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
EA200970953A1 (ru) СПЕЦИФИЧНЫЕ ИНГИБИТОРЫ PDGFRβ
SG158919A1 (en) Constructs binding to phosphatidylserine and their use in disease treatment
RS20150135A1 (en) TREATMENT WITH ANTI-VEGF ANTIBODIES
TN2009000292A1 (en) Formulations for cancer treatment
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
PH12014502507A1 (en) Anti-angiogenesis therapy for the treatment of breast cancer
UA109633C2 (uk) Антитіло людини проти тканинного фактора
DE602005018043D1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
NO20092637L (no) Fremgangsmater for behandling
MY159375A (en) Combinatorial therapy
MA34059B1 (fr) Thérapie anti-angiogénique pour le traitement du cancer des ovaires
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
BRPI0908635B8 (pt) composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica
EP2687235A3 (en) Methods for production and use of substance-loaded erythrocytes (S-LES) for observation and treatment of microvascular hemodynamics
TW200740808A (en) Inhibiteurs de proteines kinases
MX2011010911A (es) Terapia de combinacion que usa un agente o agentes anti-receptor del factor de crecimiento epidermico e inhibidores especificos del factor de crecimiento similar a insulina-1r.
MD3222F1 (ro) Metoda de diagnostic al cancerului endometrial

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees